Necrolytic migratory erythema associated with hyperglucagonemia and neuroendocrine hepatic tumors

Acta Dermatovenerologica Alpina, Pannonica et Adriatica

Volumn 14, Issue 4, 2005, Pages 161-166

  Marko, Pij B ^a   Miljković, Jovan ^a   Zemljič, Tatjana Grmek ^a  

^a UNIVERSITY MEDICAL CENTRE MARIBOR   (Slovenia)

Author keywords

Hyperglucagonemia; Necrolytic migratory erythema; Neuroendocrine hepatic tumors; Octreotide

Indexed keywords

GLUCAGON; LONG ACTING DRUG; OCTREOTIDE; RADIOISOTOPE; SOMATOSTATIN RECEPTOR;

ACRODERMATITIS; ADULT; ANEMIA; ARTICLE; AUTOPSY; CASE REPORT; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DISEASE ASSOCIATION; ERYTHEMA; EXTRAPANCREATIC GLUCAGON SECRETING TUMOR; GLUCAGONOMA; GUIDED IMAGERY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERGLUCAGONEMIA; LIVER SCINTISCANNING; LIVER TUMOR; MALE; NECROLYTIC MIGRATORY ERYTHEMA; NEEDLE BIOPSY; NEUROENDOCRINE TUMOR; PANCREAS TUMOR; PRURITUS; PSORIASIS; SKIN NECROSIS; WEIGHT REDUCTION;

ANTINEOPLASTIC AGENTS, HORMONAL; DERMATITIS; ERYTHEMA; GLUCAGON; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; OCTREOTIDE; PARANEOPLASTIC SYNDROMES;

EID: 29744467203     PISSN: 13184458     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Becker SW, Kahn, Rothman S. Cutaneous manifestations of internal malignant tumours. Arch Derm Syphilol 1942; 45: 1069-80.
2. McGavran MH, Unger RH, Recant L. A glucagon-secreting alpha-cell carcinoma of the pancreas. N Engl J Med 1966; 274(25): 1408-13.
3. Wilkinson DS. Necrolytic migratory erythema with carcinoma of the pancreas. Translation of the ST John's Hospital Dermatological Society 1973; 59: 244-50.
4. Wilkinson DS. Necrolytic migratory erythema with pancreatic carcinoma. Proceedings of the Royal Society of Medicine 1971; 64: 1179.
5. Mallinson CN, Bloom SR, Warin AP. A glucagonoma syndrome. Lancet 1979; 115: 1429-32.
6. Guillausseau PJ, Guillausseau-Scholer C. Glucagonomas: Clinical presentation, diagnosis, and advances in management. In: Endocrine tumors of the pancreas. Edited by Mignon M, Jensen RT. Front Gastrointest Res 1995; 23: 183-93.
7. Blackford S, Wright S, Roberts DL. NME without glucagon: the role of dietary essential fatty acids. Br J Dermatol 1991; 125(5): 460-2.
8. van Beek AP, de Haas ERM, van Vloten WA, Lips CJM, Rojiers JFM, Canninga-van Dijk MR. The glucagonoma syndrome and necrolytic migratory erythema: a clinical review. Eur J Endocrinol 2004; 151(5): 531-7.
9. Wermers RA, Fatourechi V, Wynne AG, Kvols LK. Clinical and pathologic features in 21 patients. Medicine 1996; 75: 53-63.
10. Marchese Johnson S, Smoller BR, Lamps LW, Horn TD. Necrolytic migratory erythema as the only presenting sign of a glucagonoma. J Am Acad Dermatol 2003; 49: 325-8.
11. Stacpoole PW. The glucagonoma syndrome: clinical features, diagnosis, and treatment. Endocrine Reviews 1981; 2: 347-61.
12. Wermers RA, Fatuorechi V, Kvols LK. Clinical spectrum of hyperglucagonemia associated with malignant neuroendocrine tumors. Mayo Clinic Proceeding 1996; 71: 1030-8.
13. Sutcliffe R, Maguire D, Ramage J, Rela M, Heaton N. Management of neuroendocrine liver metastases. Am J Surg. 2004; 187: 39-46.
14. Altimari AF, Bhoopalam N, O'Dorsio T, Lange CL, Sandberg L, Prinz RA. Use of a somatostatin analog (SMS 201-995) in the glucagonoma syndrome. Surgery 1986; 100: 989-96.
15. Wolfe MM, Alexander RW, McGuigan JE. Extrapancreatic, extraintestinal gastrinoma: Effective treatment by surgery. New Engl J Med 1982; 306: 1533-6.
16. Thompson Nw, Vinik AI, Eckhauser FE, Strodel WE. Extrapancreatic gastrinomas. Surgery 1985; 98: 1113-20.
17. Warner TFCS, Seo IS, Madura JA, Polak JM, Pearse AGE. Pancreatic-polypeptide-producing apudoma of the liver. Cancer 1980; 46: 1146-51.
18. Ali M, Fayemi AO, Braun EV. Malignant apudoma of the liver with symptomatic intractable hypoglycaemia. Cancer 1978; 42: 686-92.
19. Ballinger J. Hypoglycemia from metastasing insular carcinoma of aberrant pancreatic tissue in the liver. Arch Pathol 1941; 32: 277-85.
20. Primak A, Wilson J, O'Connor GT, Engelman K, Hull E, Canellos GP. Hepatocellular carcinoma with the carcinoid syndrome. Cancer 1971; 27: 1182-9.
21. De Giorgio R, Migliori M, Lalli S, Montini GC, Gullo L, Corinaldesi R, Bordi C, Tomasseti P. Asymptomatic Glucagonoma presenting with an isolated hepatic nodule. Hepatogastroenterology 1988; 45: 1093-6.
22. Luyckx AS, Lefebvre PJ. Les glucagonomes. Diab Metab 1981; 7: 289-300.
23. Gleeson MH, Bloom SR, Polak JM, Henry K, Dowling RH. Endocrine tumour in the kidney affecting small bowel structure, motility and absorptive function. Gut 1971; 12: 773-82.
24. Houvenaeghel G, Delpero JR, Orsoni PC, Monges G, Seitz JF, Giovannini M, Treffot MJ, Guerinel G. Localization extrapancreatique d'un glucagonome: metastase splenique prevalent d'une tumeur pancreatique meconnue ou glucagonome sur pancreas aberrant? Gastroenterol Clin Biol 1989; 13: 851.